De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery

Part of paid clinical trials in Ann Arbor, Michigan.

Sponsor
University of Michigan
Study ID
NCT06934564
Status
Recruiting

Conditions

  • Breast Lumpectomy
  • Inguinal Hernia Repair
  • Laparoscopic Cholecystectomy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Active de-Implementation — BEHAVIORAL
    During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.

Study Details

This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.

Key Dates

Start date
Apr 1, 2025
Status verified
May 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
16 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Wave 1
    Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 2
  • Experimental: Wave 2
    Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 3
  • Experimental: Wave 3
    Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 4
  • Experimental: Wave 4
    Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 1
  • Experimental: Wave 5
    Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 2
  • Experimental: Wave 6
    Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 3

Primary Outcome Measure

Number of tests within 30 days of surgery not associated with an emergency department visit [ Time Frame: Within 30 days of surgery ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Michigan and other Michigan Surgical Quality Collaborative sitesAnn ArborMichigan48109
Dana Greene Jr., MPH
(313)-670-0408
Lesly Dossett, MD, MPH (PRINCIPAL_INVESTIGATOR)
Hari Nathan, PhD (SUB_INVESTIGATOR)

Find similar trials in Ann Arbor, MI

Related Studies